Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ALB | P02768 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.33 |
| ▸ | CASP2 | P42575 | 1/20 | 0.33 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20034810 | 0.85 | FAAH (0.41) | FAAHKMT2AMEN1ALDH1A1SMN1; SMN2 | |
| SCHEMBL254104 | 0.83 | FAAH (0.44) | FAAHKMT2AMEN1ALDH1A1SMN1; SMN2 | |
| SCHEMBL20034909 | 0.79 | FAAH (0.37) | FAAHKMT2AMEN1ALDH1A1SMN1; SMN2 | |
| SCHEMBL12064338 | 0.78 | GLP1R (0.41) | FAAHKMT2AMEN1ALB | |
| SCHEMBL12743575 | 0.78 | GLP1R (0.45) | FAAHKMT2AMEN1DPP7CASP2 | |
| SCHEMBL14683490 | 0.78 | MEN1 (0.44) | FAAHKMT2AMEN1TSHR | |
| SCHEMBL12147600 | 0.78 | GLP1R (0.48) | KMT2AMEN1ALDH1A1ALBCASP2 | |
| SCHEMBL14683542 | 0.78 | GLP1R (0.43) | FAAHKMT2AMEN1ALDH1A1TSHR | |
| SCHEMBL12743587 | 0.78 | GLP1R (0.45) | FAAHKMT2AMEN1DPP7CASP2 | |
| SCHEMBL24899909 | 0.78 | KDM4E (0.56) | ALDH1A1ALBDPP7GNAI3GNAO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160303263-A1 | RADIOTRACER COMPOSITIONS AND METHODS | GE HEALTHCARE LIMITED (GB) | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160303263-A1 | RADIOTRACER COMPOSITIONS AND METHODS | MET, METTL14, MEN1 | FAAH 1581/4885KMT2A 2751/4885MEN1 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.